For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $8.52 in the prior trading day, Amneal Pharmaceuticals Inc (NASDAQ: AMRX) closed at $8.44, down -0.94%. In other words, the price has decreased by -$0.94 from its previous closing price. On the day, 0.98 million shares were traded. AMRX stock price reached its highest trading level at $8.52 during the session, while it also had its lowest trading level at $8.31.
Ratios:
Our goal is to gain a better understanding of AMRX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 52.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 58.04. For the most recent quarter (mrq), Quick Ratio is recorded 0.82 and its Current Ratio is at 1.33.
Goldman Upgraded its Sell to Buy on March 08, 2021, whereas the target price for the stock was revised from $4 to $6.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’24 when BOYER ANDREW S sold 40,225 shares for $7.85 per share. The transaction valued at 315,766 led to the insider holds 256,670 shares of the business.
BOYER ANDREW S sold 22,486 shares of AMRX for $175,616 on Aug 14 ’24. The Executive Vice President now owns 296,895 shares after completing the transaction at $7.81 per share. On Aug 14 ’24, another insider, Shah Nikita, who serves as the Executive Vice President of the company, sold 100,000 shares for $7.75 each. As a result, the insider received 775,000 and left with 291,666 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMRX now has a Market Capitalization of 2612542976 and an Enterprise Value of 5368625152. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.01. Its current Enterprise Value per Revenue stands at 2.066 whereas that against EBITDA is 9.314.
Stock Price History:
Over the past 52 weeks, AMRX has reached a high of $8.90, while it has fallen to a 52-week low of $3.36. The 50-Day Moving Average of the stock is 6.22%, while the 200-Day Moving Average is calculated to be 30.54%.
Shares Statistics:
The stock has traded on average 1.45M shares per day over the past 3-months and 1247720 shares per day over the last 10 days, according to various share statistics. A total of 306.56M shares are outstanding, with a floating share count of 119.85M. Insiders hold about 61.28% of the company’s shares, while institutions hold 39.41% stake in the company. Shares short for AMRX as of 1724976000 were 4266779 with a Short Ratio of 2.95, compared to 1722384000 on 4440971. Therefore, it implies a Short% of Shares Outstanding of 4266779 and a Short% of Float of 1.66.
